Imaging Agent Able to Detect Early and Advanced Prostate Cancers by Tracking Biomarkers

Imaging Agent Able to Detect Early and Advanced Prostate Cancers by Tracking Biomarkers
A new imaging agent may hold promise in detecting both early prostate cancer and metastasis using PET/CT scans, according to data from a first-in-human trial. The agent, a radiolabeled dual-receptor, was shown to effectively track cancer cells, and have the potential to improve prostate cancer diagnosis and guide treatment decisions. The study, “Clinical Translation Of A Dual Integrin αvβ3

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , , .

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

One comment

  1. Ralph Rousseau says:

    3 years ago I had cryotherpy to clear prostate cancer(2 out of 12 points)-psa down to .04(?) next 3 years climbed to 33. even though passing ALL ct-pet-bone-mri-scans & Biopsy -CLEAR -Dr. concerned – me too- at 80(in June)- don’t want any more ups and downs – so whats what – Dr. having me do an Axumin Pet Scan to find out what s what – COMMENTS PLEASE

Leave a Comment

Your email address will not be published. Required fields are marked *